Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors)
Philipp Harter, David Gershenson, Catherine Lhomme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2005
Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy
Lynn C Hartmann, Karen H Lu, Gerald P Linette, et al.
Gynecologic Oncology
|
November 28, 2017
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study
Neil S Horowitz, G Larry Maxwell, Austin Miller, et al.
Gynecologic Oncology
|
November 24, 2022
Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer
Shannon N Westin, Siqing Fu, Apostolia Tsimberidou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 6, 2011
Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer
Jonathan A Ledermann, Christian Marth, Mark S Carey, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 7, 2024
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer
Rachel Grisham, Bradley J Monk, Els Van Nieuwenhuysen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
Ovarian cancer, version 3.2012
Robert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 25, 2014
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors)
Philipp Harter, David Gershenson, Catherine Lhomme, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2005
Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy
Lynn C Hartmann, Karen H Lu, Gerald P Linette, et al.
Gynecologic Oncology
|
November 28, 2017
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study
Neil S Horowitz, G Larry Maxwell, Austin Miller, et al.
Gynecologic Oncology
|
November 24, 2022
Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer
Shannon N Westin, Siqing Fu, Apostolia Tsimberidou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 6, 2011
Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer
Jonathan A Ledermann, Christian Marth, Mark S Carey, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 7, 2024
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer
Rachel Grisham, Bradley J Monk, Els Van Nieuwenhuysen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
Ovarian cancer, version 3.2012
Robert J Morgan, Ronald D Alvarez, Deborah K Armstrong, et al.
Page
of 3